An Open-label, Randomised, Crossover, Single-dose, Study in Healthy Subjects to Compare the Pharmacokinetics of Two Formulations of a Strong Pain Killer With a Marketed Reference Product in a Fasted or Fed State
Phase of Trial: Phase I
Latest Information Update: 30 Sep 2015
Price : $35 *
At a glance
- Drugs MR XXX (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Mundipharma Research
- 25 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Feb 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
- 26 May 2014 New trial record